Intermittent preventive therapy with sulfadoxine-pyrimethamine during pregnancy: Seeking information on optimal dosing frequency

Journal of Infectious Diseases

Volumn 196, Issue 11, 2007, Pages 1574-1576

  Ter Kuile, Feiko O ^a   Steketee, Richard W ^b,c  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b Malaria Control and Evaluation Partnership in Africa   (France)

^c Liverpool School of Tropical Medicine ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; FANSIDAR; ANTIMALARIAL AGENT; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE; UNCLASSIFIED DRUG;

CLINICAL TRIAL; HEALTH HAZARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MALARIA; MALARIA CONTROL; NOTE; PATIENT CARE; PREGNANCY; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION; ADULT; AIDS RELATED COMPLEX; DISEASE PREDISPOSITION; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; INCIDENCE; PREGNANCY COMPLICATION; ZAMBIA;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIMALARIALS; DISEASE SUSCEPTIBILITY; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HUMANS; INCIDENCE; MALARIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PYRIMETHAMINE; SULFADOXINE; ZAMBIA;

EID: 38449083040     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/522233     Document Type: Note

References (13)

1. Roll Back Malaria Partnership. Roll back malaria global strategic plan 2005-2015. Geneva: Roll Back Malaria Partnership Secretariat, 2005.
2. World Health Organization (WHO). A strategic framework for malaria prevention and control during pregnancy in the African region. Brazzaville: WHO Regional Office for Africa, 2004.
3. Crawley J, Hill J, Yartey J, et al. From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy. Lancet Infect Dis 2007; 7:145-55.
4. Parise ME, Ayisi JG, Nahlen BL, et al. Efficacy of sulfadoxine- pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998; 59:813-22.
5. Filler SJ, Kazembe P, Thigpen M, et al. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis 2006; 194:286-93.
6. World Health Organization (WHO). Malaria and HIV/AIDS interactions and implications: conclusions of a technical consultation convened by WHO, 23-25.06.2004. WHO/HIV/2004.08. Geneva: WHO, 2004.
7. Hamer DH, Mwanakasale V, MacLeod WB, et al. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. J Infect Dis 2007; 196:1585-94 (in this issue).
8. Gill CJ, MacLeod WB, Mwanakasale V, et al. Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women. J Infect Dis 2007; 196:1577-84 (in this issue).
9. van Eijk AM, Ayisi JG, ter Kuile FO, et al. HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya. AIDS 2003; 17:595-603.
10. Gamble C, Ekwaru PJ, Garner P, Ter Kuile FO. Insecticide-treated nets for the prevention of malaria in pregnancy: a systematic review of randomised controlled trials. PLoS Med 2007; 4:e107.
11. ter Kuile FO, van Eijk AM, Filler SJ. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA 2007; 297:2603-16.
12. Mbaye A, Richardson K, Balajo B, et al. Arandomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae. Trop Med Int Health 2006; 11:992-1002.
13. Green MD, van Eijk AM, ter Kuile FO, et al. Pharmacokinetics of sulfadoxine and pyrimethamine in HIV-infected and uninfected pregnant women in western Kenya. J Infect Dis (in press).